AU2006267047A1 - Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate - Google Patents
Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate Download PDFInfo
- Publication number
- AU2006267047A1 AU2006267047A1 AU2006267047A AU2006267047A AU2006267047A1 AU 2006267047 A1 AU2006267047 A1 AU 2006267047A1 AU 2006267047 A AU2006267047 A AU 2006267047A AU 2006267047 A AU2006267047 A AU 2006267047A AU 2006267047 A1 AU2006267047 A1 AU 2006267047A1
- Authority
- AU
- Australia
- Prior art keywords
- chitosan
- poly
- particles
- hemostatic
- mesh material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001661 Chitosan Polymers 0.000 title claims description 46
- 239000000463 material Substances 0.000 title claims description 38
- 229920000642 polymer Polymers 0.000 title claims description 20
- 229940030225 antihemorrhagics Drugs 0.000 title claims description 15
- 239000002874 hemostatic agent Substances 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 15
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 title claims description 13
- 230000002439 hemostatic effect Effects 0.000 title description 7
- 230000000712 assembly Effects 0.000 title description 3
- 238000000429 assembly Methods 0.000 title description 3
- 239000000203 mixture Substances 0.000 title description 3
- 239000002245 particle Substances 0.000 claims description 46
- 239000008187 granular material Substances 0.000 claims description 26
- 230000000740 bleeding effect Effects 0.000 claims description 13
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 2
- 208000032843 Hemorrhage Diseases 0.000 description 22
- 208000014674 injury Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 230000006378 damage Effects 0.000 description 16
- 239000011159 matrix material Substances 0.000 description 15
- 239000012620 biological material Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229920001477 hydrophilic polymer Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 239000003356 suture material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 101000882917 Penaeus paulensis Hemolymph clottable protein Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000009852 coagulant defect Effects 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000011361 granulated particle Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229930182851 human metabolite Natural products 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 206010022694 intestinal perforation Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000002993 sponge (artificial) Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0094—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A61F2013/00472—Plasters use haemostatic with chemical means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
- A61F2013/00931—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors chitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Composite Materials (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69873405P | 2005-07-13 | 2005-07-13 | |
| US60/698,734 | 2005-07-13 | ||
| PCT/US2006/027496 WO2007009090A2 (en) | 2005-07-13 | 2006-07-13 | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2006267047A1 true AU2006267047A1 (en) | 2007-01-18 |
Family
ID=37637971
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006267047A Abandoned AU2006267047A1 (en) | 2005-07-13 | 2006-07-13 | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate |
| AU2006268143A Abandoned AU2006268143A1 (en) | 2005-07-13 | 2006-07-13 | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006268143A Abandoned AU2006268143A1 (en) | 2005-07-13 | 2006-07-13 | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070166387A1 (https=) |
| EP (2) | EP1906895A2 (https=) |
| JP (2) | JP2009502749A (https=) |
| KR (2) | KR20080030094A (https=) |
| CN (2) | CN101594887A (https=) |
| AU (2) | AU2006267047A1 (https=) |
| CA (2) | CA2614750A1 (https=) |
| IL (2) | IL188682A0 (https=) |
| WO (2) | WO2007009090A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
| BR0210406A (pt) | 2001-06-14 | 2006-04-04 | Providence Health Sys Oregon | curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo |
| US9204957B2 (en) | 2005-03-17 | 2015-12-08 | Hemcon Medical Technologies, Inc. | Systems and methods for hemorrhage control and or tissue repair |
| JP5160102B2 (ja) * | 2006-02-14 | 2013-03-13 | 甲陽ケミカル株式会社 | 非晶質の部分脱アセチル化キチン塩のスポンジ状止血材及びその製造方法 |
| JP2009538192A (ja) | 2006-05-23 | 2009-11-05 | プロビデンス ヘルス システム−オレゴン ディー／ビー／エー プロビデンス セント ビンセント メディカル センター | 体の内腔または体の中空器官内に包帯構造を導入および適用するシステムおよび方法 |
| JP5581208B2 (ja) * | 2007-07-18 | 2014-08-27 | データレース リミテッド | レーザー感受性被覆配合物 |
| GB2461019B (en) * | 2008-04-25 | 2013-06-05 | Medtrade Products Ltd | Haemostatic material |
| AU2009241687A1 (en) | 2008-05-02 | 2009-11-05 | Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center | Wound dressing devices and methods |
| EP2340002B1 (en) | 2008-10-06 | 2015-03-25 | Providence Health System - Oregon | Foam medical devices and methods |
| CN101862469B (zh) * | 2010-05-28 | 2013-03-13 | 武汉人福医疗用品有限公司 | 一种壳聚糖衍生物快速止血颗粒及其制备方法 |
| US9561300B2 (en) | 2011-09-26 | 2017-02-07 | Yes, Inc. | Hemostatic compositions and dressings for bleeding |
| US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
| GB2514597A (en) * | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
| GB2514592A (en) * | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
| CN104874029B (zh) * | 2015-03-30 | 2018-04-27 | 陕西佰傲再生医学有限公司 | 一种止血防粘连材料及其制备方法 |
| TR201713929A2 (tr) | 2017-09-20 | 2019-04-22 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari |
| US12156791B2 (en) | 2017-12-29 | 2024-12-03 | Tricol Biomedical, Inc. | Chitosan dressing for control of bleeding in transurethral prostatectomy |
| CN111787892B (zh) * | 2017-12-29 | 2025-02-18 | 金珂生物医疗公司 | 抵抗溶解的组织粘附脱乙酰壳多糖材料 |
| US11660236B2 (en) | 2017-12-29 | 2023-05-30 | Tricol Biomedical, Inc. | Delivery systems for control of bleeding in transurethral prostatectomy |
| KR102521769B1 (ko) * | 2020-07-20 | 2023-04-14 | 주식회사 테라시온바이오메디칼 | 국소 지혈 파우더 조성물 및 이의 제조방법 |
| CN114848668B (zh) * | 2021-01-20 | 2024-03-26 | 香港中文大学 | 具有促进伤口愈合和快速止血功能的组合物 |
| CN120919383B (zh) * | 2025-10-13 | 2025-12-05 | 吉林大学 | 一种用于腹腔镜手术的医用海绵及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2923664A (en) * | 1957-09-11 | 1960-02-02 | Johnson & Johnson | Hemostatic product |
| US4958011A (en) * | 1983-06-27 | 1990-09-18 | Bade Maria L | Ester-stabilized chitin |
| JPS61240963A (ja) * | 1985-04-18 | 1986-10-27 | ユニチカ株式会社 | 創傷被覆保護材 |
| US4952618A (en) * | 1988-05-03 | 1990-08-28 | Minnesota Mining And Manufacturing Company | Hydrocolloid/adhesive composition |
| US4948540A (en) * | 1988-08-01 | 1990-08-14 | Semex Medical, Inc. | Method of preparing collagen dressing sheet material |
| US5206028A (en) * | 1991-02-11 | 1993-04-27 | Li Shu Tung | Dense collagen membrane matrices for medical uses |
| US5836970A (en) * | 1996-08-02 | 1998-11-17 | The Kendall Company | Hemostatic wound dressing |
| WO1998051711A1 (fr) * | 1997-05-14 | 1998-11-19 | Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forestry And Fisherries | Perles de chitine, perles de chitosane, leur procede de production, vehicule comprenant lesdites perles, et procede de preparation d'une spore de microsporidie |
| JP5031144B2 (ja) * | 1999-03-25 | 2012-09-19 | メタボリックス，インコーポレイテッド | ポリヒドロキシアルカノエートポリマーの医療デバイスおよび医療適用 |
| BR0210406A (pt) * | 2001-06-14 | 2006-04-04 | Providence Health Sys Oregon | curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo |
| JP4955156B2 (ja) * | 2001-06-25 | 2012-06-20 | ユニチカ株式会社 | 止血材 |
| US6992233B2 (en) * | 2002-05-31 | 2006-01-31 | Medafor, Inc. | Material delivery system |
| US20050137512A1 (en) * | 2003-12-23 | 2005-06-23 | Campbell Todd D. | Wound dressing and method for controlling severe, life-threatening bleeding |
| ES2527857T3 (es) * | 2003-05-08 | 2015-01-30 | Tepha, Inc. | Tejidos y fibras médicas de polihidroxialcanoato |
-
2006
- 2006-07-13 KR KR1020087003422A patent/KR20080030094A/ko not_active Withdrawn
- 2006-07-13 CA CA002614750A patent/CA2614750A1/en not_active Abandoned
- 2006-07-13 JP JP2008521664A patent/JP2009502749A/ja active Pending
- 2006-07-13 WO PCT/US2006/027496 patent/WO2007009090A2/en not_active Ceased
- 2006-07-13 US US11/485,857 patent/US20070166387A1/en not_active Abandoned
- 2006-07-13 EP EP06787219A patent/EP1906895A2/en not_active Withdrawn
- 2006-07-13 CN CNA2006800308228A patent/CN101594887A/zh active Pending
- 2006-07-13 WO PCT/US2006/027279 patent/WO2007009050A2/en not_active Ceased
- 2006-07-13 AU AU2006267047A patent/AU2006267047A1/en not_active Abandoned
- 2006-07-13 CA CA002615058A patent/CA2615058A1/en not_active Abandoned
- 2006-07-13 JP JP2008521624A patent/JP2009505685A/ja active Pending
- 2006-07-13 KR KR1020087003424A patent/KR20080044238A/ko not_active Withdrawn
- 2006-07-13 CN CNA200680033731XA patent/CN101547686A/zh active Pending
- 2006-07-13 AU AU2006268143A patent/AU2006268143A1/en not_active Abandoned
- 2006-07-13 EP EP06787408A patent/EP1906896A4/en not_active Withdrawn
-
2008
- 2008-01-09 IL IL188682A patent/IL188682A0/en unknown
- 2008-01-09 IL IL188683A patent/IL188683A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007009050A3 (en) | 2009-06-11 |
| US20070166387A1 (en) | 2007-07-19 |
| EP1906895A2 (en) | 2008-04-09 |
| CN101547686A (zh) | 2009-09-30 |
| JP2009502749A (ja) | 2009-01-29 |
| JP2009505685A (ja) | 2009-02-12 |
| AU2006268143A8 (en) | 2008-03-20 |
| EP1906896A2 (en) | 2008-04-09 |
| KR20080044238A (ko) | 2008-05-20 |
| CA2614750A1 (en) | 2007-01-18 |
| WO2007009090A3 (en) | 2008-11-06 |
| CA2615058A1 (en) | 2007-01-18 |
| WO2007009050A2 (en) | 2007-01-18 |
| WO2007009090A2 (en) | 2007-01-18 |
| CN101594887A (zh) | 2009-12-02 |
| IL188682A0 (en) | 2008-08-07 |
| AU2006268143A1 (en) | 2007-01-18 |
| KR20080030094A (ko) | 2008-04-03 |
| EP1906896A4 (en) | 2009-05-27 |
| IL188683A0 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070166387A1 (en) | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate | |
| US8951565B2 (en) | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan | |
| Mecwan et al. | Recent advances in biopolymer-based hemostatic materials | |
| Guo et al. | Advances in the development and optimization strategies of the hemostatic biomaterials | |
| JP5883895B2 (ja) | 生物相容性の止血、癒着防止、癒合促進、外科密封可能な変性澱粉材料 | |
| CN102600013B (zh) | 一种医用植绒止血材料及其制备和应用 | |
| AU2016350050B2 (en) | Hemostatic composition | |
| EP1830755A2 (en) | Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chitosan | |
| JP2011509932A5 (https=) | ||
| EP2173293A1 (en) | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan | |
| WO2014197685A1 (en) | Hydrogel pressure sealant system | |
| Liu et al. | A tough and mechanically stable adhesive hydrogel for non-invasive wound repair | |
| IL184044A (en) | Antimicrobial barriers including a chitosan biomaterial and methods for the manufacture thereof | |
| Zhu et al. | Biological application of novel biodegradable cellulose composite as a hemostatic material | |
| CN101283025B (zh) | 生物降解性粒子及其制造方法 | |
| EP3903808A1 (en) | Hemostatic composition and receptacle comprising same | |
| CN116983461B (zh) | 基于脂质体修饰的止血海绵体系 | |
| McCarthy | HEMOSTATIC COMPOSITIONS, ASSEMBLIES, SYSTEMS, AND METHODS EMPLOYING PARTICULATE HEMOSTATIC US PATENT DOCUMENTS AGENTS FORMED FROM HYDROPHILIC POLYMER FOAM SUCH AS CHITOSAN | |
| JP5940987B2 (ja) | 生体用接着材料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |